PV pharm branch, vendor, cage 0U9U0

Ended Awarded Last action

Contract number
SPE2D826FAF9C
Awardee
Awarding agency
Obligated
$31,344

Award facts

Contract value 100% obligated
$31,343.79 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

Amerisourcebergen Drug Corp (CAGE 0U9U0), a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,343.79 by the Defense Logistics Agency's Medical Supply Chain on January 19, 2026, with completion scheduled for January 20, 2026. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits to support military healthcare programs worldwide.

As a major pharmaceutical distributor and critical federal medical procurement vendor, Amerisourcebergen Drug Corp demonstrates significant capability in fulfilling complex healthcare supply requirements for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio reflects consistent performance across competitive procurement processes, with delivery orders historically structured as firm fixed-price arrangements covering diverse therapeutic domains including diabetes management, neurological treatments, pain management, and antibiotics. The DLA Troop Support Medical is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning Amerisourcebergen to continue serving as a key supplier within the federal medical supply chain infrastructure.

Quick answers

Who was awarded contract SPE2D826FAF9C?

SPE2D826FAF9C was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 19, 2026.

How much is contract SPE2D826FAF9C worth?

The government has obligated $31,344 on SPE2D826FAF9C.

Is contract SPE2D826FAF9C an order under another contract?

Yes. SPE2D826FAF9C is a delivery order under SPE2DX22D0099, an indefinite delivery contract.

Was contract SPE2D826FAF9C competed?

The extent of competition for SPE2D826FAF9C was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award